-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Bis-5 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bis-5 in Endometrial Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bis-5 in Endometrial Cancer Drug Details: Bis5 (LB-1410) is under development for...
-
Product Insights
Gonghe Hi-Tech Wealth Solar PV Park Phase III
Gonghe Hi-Tech Wealth Solar PV Park Phase III is a solar PV project located in Hainan, China. The project was developed by NR Electric Co Ltd. The project came online in 2014. Empower your strategies with our Gonghe Hi-Tech Wealth Solar PV Park Phase III report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Adalimumab Biosimilar in Uveitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Adalimumab Biosimilar in Uveitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adalimumab biosimilar in Uveitis Drug Details: Adalimumab (Yuflyma) is a human...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Adalimumab Biosimilar in Psoriasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Adalimumab Biosimilar in Psoriasis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adalimumab biosimilar in Psoriasis Drug Details: Adalimumab (Yuflyma) is a human...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IDE-161 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IDE-161 in Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.IDE-161 in Ovarian CancerDrug Details: IDE-161 is under development for the treatment of solid tumors...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Upadacitinib ER in Systemic Idiopathic Juvenile Arthritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Upadacitinib ER in Systemic Idiopathic Juvenile Arthritis Drug Details: Upadacitinib (Rinvoq, Rim-Voq) is an antineoplastic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LCB-71 in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LCB-71 in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.LCB-71 in Diffuse Large B-Cell Lymphoma Drug Details:LCB-71 (ABL-202) is under...
-
Product Insights
Tarasovskoye South (Yuzhno-Tarasovskoye) (SLKh 14245 NR) Field, Russia
Tarasovskoye South (Yuzhno-Tarasovskoye) (SLKh 14245 NR) Field is a producing field located in Yamalo-Nenets Autonomous Okrug, Russia. It is being operated by Lukoil-Western Siberia. Empower your strategies with our Tarasovskoye South (Yuzhno-Tarasovskoye) (SLKh 14245 NR) Field, Russia report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may...
-
Product Insights
Listvenskoye South (Yuzhno-Listvenskoye) (IZhV 01802 NR) Field, Russia
Listvenskoye South (Yuzhno-Listvenskoye) (IZhV 01802 NR) Field is a producing field located in Udmurt Republic, Russia. It is being operated by Udmurtneft. Empower your strategies with our Listvenskoye South (Yuzhno-Listvenskoye) (IZhV 01802 NR) Field, Russia report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed...